Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 177Neoplasm Metastasis 142Neoplasms 136Leukemia, Myeloid, Acute 128Colorectal Neoplasms 126Breast Neoplasms 115Ovarian Neoplasms 89Melanoma 88Prostatic Neoplasms 86Recurrence 84Multiple Myeloma 81Pancreatic Neoplasms 74Squamous Cell Carcinoma of Head and Neck 72Glioblastoma 72Lung Neoplasms 70Lymphoma, Non-Hodgkin 63Myelodysplastic Syndromes 60Triple Negative Breast Neoplasms 57Glioma 53Stomach Neoplasms 52Precursor Cell Lymphoblastic Leukemia-Lymphoma 49Endometrial Neoplasms 48Carcinoma, Renal Cell 47Small Cell Lung Carcinoma 46Lymphoma, Large B-Cell, Diffuse 44Brain Neoplasms 43Carcinoma, Hepatocellular 41Sarcoma 39Lymphoma, B-Cell 39Advanced Solid Tumors 39

Interventions

atezolizumab 1Tiragolumab 1Rosuvastatin Calcium 1Radiotherapy 1Rabeprazole 1Metformin 1Furosemide 1Digoxin 1ATP Binding Cassette Transporter, Subfamily B, Member 1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Advanced Solid Malignancies × 90 days × Clear all
NCT06760481 2026-04-15

Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER)

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
7 enrolled

Advanced Solid Malignancies

NCT06899061 2026-03-27

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

AstraZeneca

Phase 1 Active not recruiting
41 enrolled

Advanced Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡